Adial Pharmaceuticals, Inc · NASDAQ:ADIL
Davidson Matt received 299,414 Adial Pharmaceuticals, Inc shares as an award (Form 4)
Traded Jun 11 to Jun 12, 2026 · Filed Jun 16, 2026
From Jun 11 to Jun 12, 2026, Davidson Matt (Director, Chief Development Officer) received 299,414 Adial Pharmaceuticals, Inc shares as an award, leaving 297,491 shares. Filed Jun 16, 2026 (Form 4).
- Awarded
- 299,414 shares
- Holding after
- 297,491 shares
- Trading plan
- No
- Role
- Director, Chief Development Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 11, 2026 | Common Stock | Award | 61,647 | 61,647 | Direct | |
| Jun 11, 2026 | Common Stock | Award | 3,427 | 3,427 | Indirect | |
| Jun 11, 2026 | Series A Preferred Stock | Award | 1,822 | 1,822 | Direct | |
| Jun 11, 2026 | Series A Preferred Stock | Award | 101 | 1,923 | Indirect | |
| Jun 12, 2026 | Common Stock | Award | 232,417 | 297,491 | Direct |
Source
Related
- Adial Pharmaceuticals, Inc
- Davidson Matt
- Adial Pharmaceuticals, Inc shareholders
- Form 4 · Coastlands Capital LP · Jul 16, 2026
- Form 4 · Coastlands Capital LP · Jul 13, 2026
- Form 4 · Coastlands Capital LP · Jul 1, 2026
- Schedule 13G/A · Coastlands Capital LP · Jul 1, 2026
- Schedule 13G · Coastlands Capital LP · Jun 24, 2026